QX
Insider selling
Quang X Pham sold $13K of CVKD stock
Quang X Pham, Chairman, CEO and Interim CFO, 10% of Cadrenal Therapeutics, Inc. (CVKD), sold 4,126 shares of CVKD stock worth $13K, per an SEC Form 4 filed Jun 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 16, 2026, 2 days before it was made public.
CVKD has moved -65.8% since the trade date, from $3.04 to $1.04 (Oct 20, 2026 close).
- Traded
- Jun 16, 2026
- Disclosed
- Jun 18, 2026
- Filing delay
- 2 days
- Price since
- -65.8%
- Role
- Chairman, CEO and Interim CFO, 10%
- Source
- SEC Form 4
More CVKD insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.